Lipid-induced secondary structures and orientations of (Leu5)-enkephalin: Helical and crystallographic double-bend conformers revealed by IRATR and molecular modelling

Journal of Peptide Science

Volumn 3, Issue 1, 1997, Pages 65-81

  Schwyzer, Robert ^a,e   Moutevelis Minakakis, Panagiota ^a,b   Kimura, Shunsaku ^a,c   Gremlich, Hans Ulrich ^a,d  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF ATHENS   (Greece)

^c KYOTO UNIVERSITY   (Japan)

^d Sandoz Pharma Ltd   (Switzerland)

^e SWISS FEDERAL INSTITUTE OF TECHNOLOGY   (Switzerland)

Author keywords

Bioactive conformation; IRATR; MMX force field; Secondary structure; Leu5 enkephalin

Indexed keywords

LEUCINE ENKEPHALIN; MEMBRANE LIPID;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER SIMULATION; INFRARED SPECTROPHOTOMETRY; METABOLISM; PROTEIN CONFORMATION; PROTEIN SECONDARY STRUCTURE; X RAY CRYSTALLOGRAPHY;

COMPUTER SIMULATION; CRYSTALLOGRAPHY, X-RAY; ENKEPHALIN, LEUCINE; MEMBRANE LIPIDS; MODELS, MOLECULAR; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; SPECTROPHOTOMETRY, INFRARED;

EID: 0030625003     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1387(199701)3:1<65::AID-PSC90>3.0.CO;2-Q     Document Type: Article

References (58)

1. J. Hughes, T. W. Smith, H. W. Kosterlitz, L. A. Fothergill, B. A. Morgan and H. R. Morris (1975). Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature, Lond. 258, 57-59.
2. H. W. Kosterlitz and S. J. Paterson (1985). Types of opioid receptors: Relation to antinociception. Phil. Trans. R. Soc. Lond. B 308, 297-297.
3. G. A. Olson, R. D. Olson and A. J. Kastin (1995). Endogenous opiates: 1994. Peptides 16, 1517-1555.
4. P. W. Schiller and J. DiMaio (1982). Opiate receptor subclasses differ in their conformational requirements. Nature 297, 74-76.
5. V. J. Hruby (1993). Conformational and topographical considerations in the design of biologically active peptides. Biopolymers 33, 1073-1082.
6. P. W. Schiller in: Handbook of Experimental Pharmacology 104/I Opioids I, A. Herz, Ed., 681-710, Springer, Berlin, 1993.
7. P. W. Schiller (1984). Conformational analysis of enkephalin and conformation-activity relationships. The Peptides 6, 219-268.
8. J. R. Deschamps, C. George and J. L. Flippen-Anderson (1996). Structural studies of opioid peptides: A review of recent papers in X-ray diffraction studies. Peptide Sci. 40, 121-139.
9. K. D. Kopple, J. W. Bean, K. K. Bhandary, J. Briand, C. A. D'Ambrosio and C. E. Peishoff (1993). Conformational mobility in cyclic oligo peptides. Biopolymers 33, 1093-1099.
10. W. Brandt, C. Mrestani-Klaus, H. Schinke, K. Neubert, A. Barth, R. Schmidt, P. W. Schiller and H. D. Höltje (1995). The mu opioid receptor binding pharmacophore conformation of ornithine containing cyclic beta-casomorphin analogues and related peptides. Quant. Struct. Act. Rel. 14, 417-426.
11. B. S. Zhorov and V. S. Ananthanarayanan (1995). Conformational analysis of the Ca2+-bound opioid peptides: Implications for ligand-receptor interaction. J. Biomol. Struct. Dynam. 13, 1-13.
12. R. Schwyzer (1986). Molecular mechanism of opioid receptor selection. Biochemistry 25, 6335-6342.
13. R. Schwyzer (1992). Conformations and orientations of amphiliphilic peptides induced by artificial lipid membranes: Correlations with biological activity. Chem-Tracts - Biochem. Molec. Biol. 3, 347-379.
14. R. Schwyzer (1995). 100 Years lock-and-key concept: Are peptide keys shaped and guided to their recepters by the target cell membrane? Biopolym. (Peptide Sci.) 37, 5-16.
15. D. Erne, D. F. Sargent and R. Schwyzer (1985). Preferred conformation, orientation, and accumulation of dynophiin A-(1-13)-tridecapeptide on the surface of neutral lipid membranes. Biochemistry 24, 4261-4263.
16. D. A. Kallick (1993). Conformation of dynorphin A (1-17) bound to dodecylphosphocholine micelles. J. Am. Chem. Soc. 115, 9317-9318.
17. D. F. Sargent and R. Schwyzer (1986). Membrane lipid phase as catalyst for peptide-receptor interactions. Proc. Natl. Acad. Sci. USA 83, 5774-5778.
18. Y. Sasaki-Yagi, S. Kimura and Y. Imanishi (1991). Binding to opioid receptors of enkephalin derivatives taking α-helical conformation and its dimer. Int. J. Peptide Protein Res. 38, 378-384.
19. N. Collins and V. J. Hruby (1994). Prediction of the conformational requirements for binding to the kappa-opioid receptor and its subtypes. I. Novel alpha-helical cyclic peptides and their role in receptor selectivity. Biopolymers 34, 1231-1241.
20. R. Schwyzer, H.-U. Gremlich, B. Gysin and U.-P. Fringeli in Peptides 1982 (Proceedings of the 17th European Peptide Symposium, Prague) K. Blaha and P. Malon, Eds., 55-71, de Gruytel, Berlin, 1993.
21. B. Gysin and R. Schwyzer (1983). Head group and structure specific interactions between enkephalins and dynorphin with liposomes: Investigation by hydrophobic photolabelling. Arch. Biochem. Biophys. 225, 467-474.
22. B. A. Behnam and C. M. Deber (1984). Evidence for a folded conformation of methionine- and leucine-enkephalin in a membrane environment. J. Biol. Chem. 259, 14935-14940.
23. C. M. Deber and B. A. Behnam (1984). Role of membrane lipids in peptide hormone function: Binding of enkephalins t micelles. Proc. Natl. Acad. Sci. USA 81, 61-65.
24. C. M. Deber and B. A. Behnam (1985). Transfer of peptide hormones from aqueous to membrane phases. Biopolymers 24, 105-116.
25. 1H nuclear magnetic resonance: correlation between activities and membrane-bound conformations. Biochemistry 29, 65-75.
26. 5-enkephalin bound to a model membrane as determined by high-resolution NMR. Lett. Peptide Sci. 2, 59-70.
27. S. Krimm and J. Bandekar (1986). Vibrational spectroscopy and conformation of peptides, polypeptides, and proteins. Adv. Protein Chem. 38, 181-364.
28. 10- and α-helices and β-bend ribbon structures in organic solution and in model biomembranes by Fourier transform infrared spectroscopy. Biochemistry 30, 6541-6548.
29. A. Aubry, N. Birlirakis, M. Sakarellos-Daitsiotis, C. Sakarellos and M. Marraud (1989). A crystal molecular conformation of leucin-enkephalin related to the morphine molecule. Biopolymers 28, 27-40.
30. H.-U. Gremlich in: Ullmann's Encyclopedia of Industrial Chemistry B5, p. 429-469. VCH Verlagsgesellschaft, Weinheim 1996.
31. H.-U. Gremlich, U.-P. Fringeli and R. Schwyzer (1983). Conformational changes of adrenocorticotropin peptides upon interaction with lipid membranes revealed by infrared attenuated total reflection spectroscopy. Biochemistry 22, 4257-4264.
32. U. P. Fringeli and H. H. Gunthard in: Membrane Spectroscopy, E. Grell, Ed., p. 270-332, Springer, Berlin 1984.
33. U. P. Fringeli (1977). The structure of lipids and proteins studies by attenuated total reflection (ATR) infrared spectroscopy. Z. Naturforsch. 32c, 20-45.
34. R. E. Dickerson and I. Geis. The Structure and Action of Proteins, Harper & Row, New York 1969.
35. E. Benedetti (1996). X-ray crystallography of peptides: The contributions of the Italian laboratories. Biopolym. (Peptide Sci) 40, 3-44.
36. 10-helix. Trends Biochem. Sci. 16, 350-353.
37. D. Erne, K. Rolka and R. Schwyzer (1986). Membrane structure of substance P: III. Secondary structure of substance P in 2, 2, 2-trifluoroethanol, methanol, and on flat lipid membranes studied by infrared spectroscopy. Helv. Chim. Acta 69 1807-1816.
38. D. Erne, and R. Schwyzer (1987). Membrane structure of bombesin studied by infrared spectroscopy. Prediction of membrane interactions of gastrin-releasing peptide, neuromedin B, and neuromedin C. Biochemistry 26, 6316-6319.
39. A. M. Dwiwedi, S. Krimm and B. R. Malcolm (1984). IR frequencies of reverse turns. Biopolymers 23, 2025-2065.
40. U. P. Fringeli, M. Schadt, P. Rihak and H. H. Gunthard (1976). Hydrocarbon chain ordering in liquid crystals investigated by means of infrared attenuated total reflection (IR-ATR) spectroscopy. Z. Naturforsch 31a, 1098-1107.
41. H.-U. Gremlich, U.-P. Fringeli and R. Schwyzer (1984). Interaction of adrenocorticotropin-(11-24)-tetradecapeptide with neural lipid membranes revealed by attenuated total reflection spectroscopy. Biochemistry 23, 1808-1810.
42. E. Goormaghtigh, L. Vigneron, M. Knibiehler, C. Lazdunski and J.-M. Ruysschaert (1991). Secondary structure of the membrane-bound form of the poreforming domain of colicin A. An attenuated total-reflection polarized Fourier-transform infrared spectroscopy study. Eur. J. Biochem. 202, 1299-1305.
43. S. Kimura, D. Erne and R. Schwyzer (1992). Interaction of glucagon with artificial lipid bililayer membranes. Int; J. Peptide Protein Res. 39, 431-442.
44. L. Lins, R. Brasseur, M. Rosseneu, C.-Y. Yang, D. A. Sparrow, J. T. Sparrow, A. M. Gotto Jr and R.-M. Ruysschaert (1994). Structure and orientation of Apo B-100 peptides into a lipid bilayer. J. Protein Chem. 13, 77-88.
45. S. A. Tatulian, L. R. Jones, L. G. Reddy, D. L. Stokes and L. K. Tamm (1995). Secondary structure and orientation of phospholamban reconstituted in supported bilayers from polarized attenuated total reflection FTIR spectroscopy. Biochemistry 34, 4448-4456.
46. Y. P. Zhang, R. Lewis, G. D. Henry, B. D. Sykes, R. S. Hodges and R. N. McElhaney (1995). Peptide models of helical hydrophobic transmembrane segments of membrane proteins. 1. Studies of the conformation, intrabilayer orientation, and amide hydrogen exchangeability of Ac-K2-(LA)12-K2-amide. Biochemistry 34, 2348-2361.
47. Y. P. Zhang, R. Lewis, R. S. Hodges and R. N. McElhaney (1995). Peptide models of helical hydrophobic transmembrane segments of membrane proteins. 2. Differential scanning calorimetric and FTIR spectroscopic studies of the interaction of Ac-K2-(LA)12-K2-amide with phosphatidylcholine bilayers. Biochemistry 34, 2362-2371.
48. R. Schwyzer (1986). Estimated conformation, orientation, and accumulation of dynorphin A-(1-13)-tridecapeptide on the surface of neutral lipid membranes. Biochemistry 25, 4281-4286.
49. S. H. White and W. C. Wimley (1994). Peptides in lipid bilayers: Structural and thermodynamic basis for partitioning and folding. Curr. Opin. Struct. Biol. 4, 79-86.
50. R. Schwyzer (1986). Membrane structure and biologic activity of adrenocorticotorpin (ACTH) and melanotropin (MSH) peptides. Estimation of structural parameters including the influence of the helix dipole moment. Helv. Chim. Acta 69, 1685-1698.
51. J. DiMaio and P. W. Schiller (1980). A cyclic enkephalin analog with high in vitro opiate activity. Proc. Natl. Acad. Sci. USA 77, 7162-7166.
52. D. A. Kallick, M. R. Tessmer, C. R. Watts and C. Y. Li (1995). The use of dodecylphosphocholine micelles in solution NMR. J. Magn. Reson. Ser. B 109, 60-65.
53. Y. Ohno, M. Segawa, H. Ohishi, M. Doi, K. Kitamura, T. Ishida, M. Inoue and T. Iwashita (1993). Conformation of deltorphin-II In membrane environment studied by two-dimensional NMR spectroscopy and molecular dynamics calculations. Eur. J. Biochem. 212, 185-191.
54. G. V. Nikiforovich, O. M. Prakash, C. A. Gehrig and V. J. Hruby (1993). Solution conformations of the peptide backbone for DPDPE and its beta-MePhe4-substituted analogues. Int. J. Peptide Protein Res. 41, 347-361.
55. B. C. Wilkes and P. W. Schiller (1992) Molecular dynamics simulation of opioid peptide analogues containing multiple conformational restriction. Int. J. Peptide Protein Res. 40, 249-254.
56. B. C. Wilkes and P. W. Schiller (1994). Theoretical conformational analysis of the opoiod delta antagonist H-Tyr-Tic-Phe-OH and the mu agonist H-Tyr-D-Tic-Phe-NH2. Biopolymers 34, 1213-1219.
57. B. C. Wilkes and P. W. Schiller (1995). Comparative analysis of various proposed models of the receptor-bound conformation of H-Tyr-Tic-Phe-OH related delta-opioid antagonist. Biopolym. (Peptide Sci.) 37, 391-400.
58. L. Moroder, R. Romano, W. Guba, D. F. Mierke, H. Kassler, C. Delporte, J, Winand and J. Christophe (1993). New evidence for a membrane-bound pathway in hormone receptor binding. Biochemistry 32, 13551-13559.